FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

PTC Therapeutics Phenylketonuria Drug Approved

[ Price : $8.95]

FDA approves a PTC Therapeutics NDA for Sephience (sepiapterin), indicated for treating adult and pediatric patients with phenylke...

User Fee Rates Set for FY 2026

[ Price : $8.95]

FDA posts the user fee rates for fiscal year 2026 for prescription drugs and biologics, biosimilar, medical devices and generic dr...

Guide on Aluminum Content in Parenteral Drugs

[ Price : $8.95]

FDA issues a revised draft guidance entitled Small Volume Parenteral (SVP) Drug Products and Pharmacy Bulk Packages for Parenteral...

FDA Probes New Death of Boy Who Got Elevidys

[ Price : $8.95]

FDA investigates another death of a young boy who received Sarepta Therapeutics gene therapy Elevidys for Duchenne muscular dystro...

Roche Reports Positive Data on Alzheimers Drug

[ Price : $8.95]

Roche announces new data on its Alzheimers therapy trontinemab and its plans to begin two Phase 3 clinical trials by the end of th...

House Reps Urge FDA Action on Counterfeit Obesity Drugs

[ Price : $8.95]

Bipartisan House lawmakers urge FDA to block counterfeit anti-obesity medications entering the U.S.

FDA Relents, Allows Gene Therapy Limited Use

[ Price : $8.95]

FDA reverses its enforcement stance against Sarepta Therapeutics and Duchenne Muscular Dystrophy gene therapy Elevidys after deter...

FDA Clears Stereotaxis MAGiC Sweep Catheter

[ Price : $8.95]

FDA clears a Stereotaxis 510(k) for its MAGiC Sweep catheter, a robotically navigated high-density electrophysiology mapping cathe...

Recognify Reports Mixed Data on Schizophrenia Drug

[ Price : $8.95]

Recognify Life Sciences says its Phase 2b trial of inidascamine, a drug candidate for treating cognitive impairment associated wit...

Input Sought on Controversial Menopause Expert Panel

[ Price : $8.95]

After being criticized for attempting to bypass a formal advisory committee review of warnings associated with hormone replacement...